Xencor, Inc Research and Development Expense
Xencor, Inc (XNCR) reported Research and Development Expense of $71.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- Xencor, Inc research and development expense for the quarter ending 2026-06-30 was $71.91M, a 16.61% increase year-over-year.
- Xencor, Inc research and development expense for the quarter ending 2026-03-31 was $64.67M, a 10.40% increase year-over-year.
- Xencor, Inc research and development expense for the quarter ending 2025-12-31 was $64.82M, a 26.97% increase year-over-year.
- Xencor, Inc research and development expense for the quarter ending 2025-09-30 was $54.37M, a 6.63% decline year-over-year.
- Xencor, Inc research and development expense for fiscal 2025 was $239.43M, a 5.16% increase from fiscal 2024.
- Xencor, Inc research and development expense for fiscal 2024 was $227.69M, a 10.22% decline from fiscal 2023.
- Xencor, Inc research and development expense for fiscal 2023 was $253.60M, a 27.08% increase from fiscal 2022.
- Xencor, Inc research and development expense for fiscal 2022 was $199.56M, a 3.67% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $71.91M 10-Q · filed 2026-08-05 | $136.57M 10-Q · filed 2026-08-05 | $201.40M derived: sum of 3 quarters · filed 2026-08-05 | $255.76M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $64.67M 10-Q · filed 2026-05-06 | $129.49M derived: sum of 2 quarters · filed 2026-05-06 | $183.86M derived: sum of 3 quarters · filed 2026-05-06 | $245.53M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $64.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $119.19M derived: sum of 2 quarters · filed 2026-02-25 | $180.86M derived: sum of 3 quarters · filed 2026-08-05 | $239.43M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $54.37M 10-Q · filed 2025-11-05 | $116.03M derived: sum of 2 quarters · filed 2026-08-05 | $174.61M 10-Q · filed 2025-11-05 | $225.67M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $61.66M 10-Q · filed 2026-08-05 | $120.24M 10-Q · filed 2026-08-05 | $171.30M derived: sum of 3 quarters · filed 2026-08-05 | $229.53M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $58.58M 10-Q · filed 2026-05-06 | $109.63M derived: sum of 2 quarters · filed 2026-05-06 | $167.86M derived: sum of 3 quarters · filed 2026-05-06 | $229.39M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $51.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $109.28M derived: sum of 2 quarters · filed 2026-02-25 | $170.81M derived: sum of 3 quarters · filed 2026-02-25 | $227.69M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $58.23M 10-Q · filed 2025-11-05 | $119.76M derived: sum of 2 quarters · filed 2025-11-05 | $176.63M 10-Q · filed 2025-11-05 | $239.68M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $61.53M 10-Q · filed 2025-08-06 | $118.40M 10-Q · filed 2025-08-06 | $181.45M derived: sum of 3 quarters · filed 2026-02-25 | $246.39M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | $56.87M 10-Q · filed 2025-05-07 | $119.92M derived: sum of 2 quarters · filed 2026-02-25 | $184.86M derived: sum of 3 quarters · filed 2026-02-25 | $244.92M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $63.05M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | $127.99M derived: sum of 2 quarters · filed 2026-02-25 | $188.05M derived: sum of 3 quarters · filed 2026-02-25 | $253.60M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $64.94M 10-Q/A · filed 2025-02-24 | $64.94M 10-Q · filed 2023-11-08 | $125.00M derived: sum of 2 quarters · filed 2025-02-24 | $190.55M 10-Q/A · filed 2025-02-24 | $189.38M 10-Q · filed 2023-11-08 | $242.00M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $60.06M 10-Q/A · filed 2025-02-24 | $125.61M 10-Q/A · filed 2025-02-24 | $124.44M 10-Q · filed 2023-08-03 | $177.06M derived: sum of 3 quarters · filed 2025-02-27 | $230.34M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $65.55M 10-Q/A · filed 2025-02-24 | $64.38M 10-Q · filed 2023-05-08 | $117.00M derived: sum of 2 quarters · filed 2025-02-27 | $170.28M derived: sum of 3 quarters · filed 2025-02-27 | $217.36M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $51.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $104.72M derived: sum of 2 quarters · filed 2025-02-27 | $151.81M derived: sum of 3 quarters · filed 2025-02-27 | $199.56M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $53.27M 10-Q · filed 2023-11-08 | $100.36M derived: sum of 2 quarters · filed 2023-11-08 | $148.11M 10-Q · filed 2023-11-08 | $199.10M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-06-30 | $47.08M 10-Q · filed 2023-08-03 | $94.84M 10-Q · filed 2023-08-03 | $145.83M derived: sum of 3 quarters · filed 2025-02-24 | $196.44M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-03-31 | $47.76M 10-Q · filed 2023-05-08 | $98.74M derived: sum of 2 quarters · filed 2025-02-24 | $149.35M derived: sum of 3 quarters · filed 2025-02-24 | $198.85M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2021-12-31 | $50.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $101.60M derived: sum of 2 quarters · filed 2025-02-24 | $151.09M derived: sum of 3 quarters · filed 2025-02-24 | $192.51M 10-K/A · filed 2025-02-24 | |||
| 2021-09-30 | $50.61M 10-Q · filed 2022-11-07 | $100.11M derived: sum of 2 quarters · filed 2022-11-07 | $141.52M 10-Q · filed 2022-11-07 | $189.47M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | $49.50M 10-Q · filed 2022-08-03 | $90.91M 10-Q · filed 2022-08-03 | $138.86M derived: sum of 3 quarters · filed 2023-02-27 | $183.31M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | $41.41M 10-Q · filed 2022-05-05 | $89.36M derived: sum of 2 quarters · filed 2023-02-27 | $133.81M derived: sum of 3 quarters · filed 2023-02-27 | $177.27M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $47.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $92.40M derived: sum of 2 quarters · filed 2023-02-27 | $135.86M derived: sum of 3 quarters · filed 2023-02-27 | $169.80M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $44.45M 10-Q · filed 2021-11-08 | $87.91M derived: sum of 2 quarters · filed 2021-11-08 | $121.85M 10-Q · filed 2021-11-08 | $149.19M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $43.46M 10-Q · filed 2021-08-04 | $77.40M 10-Q · filed 2021-08-04 | $104.74M derived: sum of 3 quarters · filed 2022-02-24 | $134.51M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $33.94M 10-Q · filed 2021-05-05 | $61.28M derived: sum of 2 quarters · filed 2022-02-24 | $91.05M derived: sum of 3 quarters · filed 2022-02-24 | $124.35M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $27.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $57.11M derived: sum of 2 quarters · filed 2022-02-24 | $90.41M derived: sum of 3 quarters · filed 2022-02-24 | $118.59M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $29.77M 10-Q · filed 2020-11-06 | $63.07M derived: sum of 2 quarters · filed 2020-11-06 | $91.25M 10-Q · filed 2020-11-06 | $118.38M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $33.30M 10-Q · filed 2020-08-05 | $61.48M 10-Q · filed 2020-08-05 | $88.61M derived: sum of 3 quarters · filed 2021-02-24 | $109.56M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $28.18M 10-Q · filed 2020-05-08 | $55.31M derived: sum of 2 quarters · filed 2021-02-24 | $76.27M derived: sum of 3 quarters · filed 2021-02-24 | $99.60M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $27.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $48.08M derived: sum of 2 quarters · filed 2021-02-24 | $71.42M derived: sum of 3 quarters · filed 2021-02-24 | $97.50M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $20.95M 10-Q · filed 2019-11-05 | $44.28M derived: sum of 2 quarters · filed 2019-11-05 | $70.37M 10-Q · filed 2019-11-05 | $90.77M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $23.33M 10-Q · filed 2019-08-07 | $49.42M 10-Q · filed 2019-08-07 | $69.81M derived: sum of 3 quarters · filed 2020-02-25 | $89.22M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $26.09M 10-Q · filed 2019-05-09 | $46.48M derived: sum of 2 quarters · filed 2020-02-25 | $65.89M derived: sum of 3 quarters · filed 2020-02-25 | $82.81M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $20.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $39.80M derived: sum of 2 quarters · filed 2020-02-25 | $56.72M derived: sum of 3 quarters · filed 2020-02-25 | $71.77M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $19.41M 10-Q · filed 2018-11-05 | $36.33M derived: sum of 2 quarters · filed 2018-11-05 | $51.38M 10-Q · filed 2018-11-05 | $64.73M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $16.92M 10-Q · filed 2018-08-07 | $31.97M 10-Q · filed 2018-08-07 | $45.33M derived: sum of 3 quarters · filed 2019-02-26 | $59.40M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $15.05M 10-Q · filed 2018-05-07 | $28.41M derived: sum of 2 quarters · filed 2019-02-26 | $42.48M derived: sum of 3 quarters · filed 2019-02-26 | $56.88M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $27.43M derived: sum of 2 quarters · filed 2019-02-26 | $41.84M derived: sum of 3 quarters · filed 2019-02-26 | $51.87M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $14.07M 10-Q · filed 2017-11-08 | $28.48M derived: sum of 2 quarters · filed 2017-11-08 | $38.51M 10-Q · filed 2017-11-08 | $49.39M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $14.41M 10-Q · filed 2017-08-07 | $24.44M 10-Q · filed 2017-08-07 | $35.32M derived: sum of 3 quarters · filed 2018-02-28 | $45.90M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $10.04M 10-Q · filed 2017-05-10 | $20.91M derived: sum of 2 quarters · filed 2018-02-28 | $31.49M derived: sum of 3 quarters · filed 2018-02-28 | $38.97M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $21.46M derived: sum of 2 quarters · filed 2018-02-28 | $28.93M derived: sum of 3 quarters · filed 2018-02-28 | $34.14M 10-K · filed 2018-02-28 | |||
| 2015-09-30 | $10.58M 10-Q · filed 2016-11-02 | $18.06M derived: sum of 2 quarters · filed 2016-11-02 | $23.26M 10-Q · filed 2016-11-02 | $28.32M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $7.48M 10-Q · filed 2016-08-03 | $12.68M 10-Q · filed 2016-08-03 | $17.73M derived: sum of 3 quarters · filed 2017-03-01 | $22.69M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $5.21M 10-Q · filed 2016-05-02 | $10.26M derived: sum of 2 quarters · filed 2017-03-01 | $15.21M derived: sum of 3 quarters · filed 2017-03-01 | $19.49M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $5.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $10.01M derived: sum of 2 quarters · filed 2017-03-01 | $14.29M derived: sum of 3 quarters · filed 2017-03-01 | $18.52M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $4.95M 10-Q · filed 2015-11-04 | $9.24M derived: sum of 2 quarters · filed 2015-11-04 | $13.46M 10-Q · filed 2015-11-04 | $17.61M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-06-30 | $4.28M 10-Q · filed 2015-08-05 | $8.51M 10-Q · filed 2015-08-05 | $12.65M derived: sum of 3 quarters · filed 2016-03-08 | $16.82M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-03-31 | $4.23M 10-Q · filed 2015-05-05 | $8.37M derived: sum of 2 quarters · filed 2016-03-08 | $12.53M derived: sum of 3 quarters · filed 2016-03-08 | $16.67M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2013-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $8.31M derived: sum of 2 quarters · filed 2016-03-08 | $12.44M derived: sum of 3 quarters · filed 2016-03-08 | $17.00M 10-K · filed 2016-03-08 | |||
| 2013-09-30 | $4.16M 10-Q · filed 2014-11-10 | $8.30M derived: sum of 2 quarters · filed 2014-11-10 | $12.86M 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | $4.13M 10-Q · filed 2014-08-01 | $8.69M 10-Q · filed 2014-08-01 | |||||
| 2013-03-31 | $4.56M 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | $12.67M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |